Diana I. Brixner, RPh, PhD, FAMCP, is currently Professor in the Department of Pharmacotherapy at the University of Utah College of Pharmacy in Salt Lake City and Executive Director of the Department’s Outcomes Research Center. Her focus is on the design, conduct, and communication of pharmacoeconomic and outcomes research studies to demonstrate the value of pharmaceutical and related therapies. Dr. Brixner holds adjunct faculty positions in the School of Medicine’s Department of Pediatrics Division of Clinical Pharmacology and in the Department of Population Health Sciences Division of Health Systems Innovation Research. She is also an associate member of the Huntsman Cancer Institute Cancer Control and Population Sciences research program.
Dr. Brixner is appointed as a Research Associate at the Institute of Public Health, Medical Decision Making and Health Technology Assessment in the Department of Public Health and Health Technology Assessment at UMIT - University for Health Sciences, Medical Informatics and Technology in Hall i.T., Austria. The appointment supports her international collaborations in oncology research, personalized medicine and value assessment.
Diana is particularly active in oncology and policy research. During her career, Dr. Brixner has published numerous articles in peer-reviewed journals, including the Journal of National Cancer Center Networks, Value in Health, Pharmacoepidemiology and Drug Safety, the American Journal of Managed Care and the Journal of Managed Care Pharmacy, authored three book chapters, has one issued patent, has been an invited speaker at a variety of national and international professional meetings. She is a founding member, served on the Executive Board, currently serves on the Real-World Evidence Task Force and is a past president of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR). She is also a long-standing member of the Academy of Managed Care Pharmacy (AMCP), has served a previous two-year term on the Board of Directors, is a Fellow of the Academy and served as the past president of the AMCP.